Sarvodaya Hospital, Faridabad, Delhi NCR, inaugurates its Theranostics and Nuclear Medicine centre in India to offer Terbium-161 PSMA therapy for prostate cancer treatment. The centre offers treatment to patients with advanced metastatic castration resistant / hormone-refractory prostate cancer.
Sarvodaya Cancer Institute has also introduced CAR-T Cell therapy for treatments like blood cancers like leukaemia, lymphoma, and multiple myeloma. With this, the hospital now offers complete cancer care, from diagnosis to advanced treatment, all under one roof.
Dr Swagat Dash, HOD & Senior Consultant – Nuclear Medicine, Sarvodaya Cancer Institute, Sarvodaya Hospital, Faridabad, leading the initiative, stated, “This marks a significant step in precision oncology, and the team at Sarvodaya remains committed to delivering advanced and cutting-edge cancer care.”
Dr Dinesh Pendharkar, Director, Sarvodaya Cancer Institute, Sarvodaya Hospital, Faridabad, said, “We are shifting the landscape in terms of what complete cancer care means with CAR-T Cell therapy as well as Theranostics.”